Ovary testis transcribed is a protein whose functional activity can be inhibited through various mechanisms, each targeting specific cellular pathways and processes crucial to its activity. The kinase inhibitors Staurosporine, Dasatinib, Erlotinib, Imatinib, and Lapatinib play a significant role in this inhibition. Staurosporine broadly inhibits protein kinases, preventing the phosphorylation processes essential for the activation or modification of ovary testis transcribed. Dasatinib, Erlotinib, Imatinib, and Lapatinib, each with specific kinase targets, disrupt the signaling pathways that regulate or influence the activity of ovary testis transcribed. Dasatinib's inhibition of tyrosine kinases like BCR-ABL, c-Kit, and PDGFR, Erlotinib's targeting of EGFR, and Lapatinib's dual inhibition of EGFR and HER2/neu are examples of how these chemicals disrupt signaling cascades, leading to reduced activity of ovary testis transcribed.
Moreover, inhibitors like LY294002, Wortmannin, Rapamycin, PD98059, SB203580, SP600125, and U0126, each targeting different aspects of cellular signaling, contribute to the inhibition of ovary testis transcribed. LY294002 and Wortmannin, both PI3K inhibitors, disrupt crucial signaling pathways for ovary testis transcribed's functionality, leading to its inhibition. Rapamycin's targeting of the mTOR pathway affects protein synthesis and cell growth processes vital for the protein's function or post-translational modifications. PD98059 and U0126 inhibit the MEK enzymes in the MAPK/ERK pathway, reducing ERK activity, which is likely involved in the regulation of ovary testis transcribed. SB203580 and SP600125, targeting the p38 MAPK and JNK pathways, respectively, impact stress responses and other cellular processes in which ovary testis transcribed is involved. The collective action of these inhibitors, through their specific targets, contributes to the functional inhibition of ovary testis transcribed, demonstrating the intricate interplay between cellular signaling pathways and protein functionality.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases which are likely involved in the phosphorylation of ovary testis transcribed, thus preventing its activation or functional modification. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, disrupting signaling pathways crucial for ovary testis transcribed's activity, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, affecting protein synthesis and cell growth processes vital for ovary testis transcribed's function or post-translational modifications. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK in the MAPK/ERK pathway, reducing ERK activity and potentially inhibiting ovary testis transcribed's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, decreasing the functional activity of ovary testis transcribed by affecting stress response pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, reducing the functional activity of ovary testis transcribed by affecting cellular processes it is involved in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK/ERK pathway, reducing activity of downstream targets including ovary testis transcribed. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, disrupting signaling pathways essential for ovary testis transcribed's function, leading to its inhibition. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib inhibits tyrosine kinases, reducing ovary testis transcribed's activity by affecting relevant signaling pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits EGFR tyrosine kinase, affecting signaling important for ovary testis transcribed and reducing its activity. | ||||||